Cavalier David 4
4 · Anixa Biosciences Inc · Filed Oct 9, 2018
Insider Transaction Report
Form 4
Cavalier David
Director
Transactions
- Award
Employee Stock Option (Right to Buy)
2018-10-08+45,000→ 45,000 totalExercise: $5.29Exp: 2028-10-08→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]Right-To-Buy, granted under the Anixa Biosciences, Inc. 2010 Share Incentive Plan.
- [F2]The options vest and become exercisable in twelve (12) equal monthly installments beginning October 31, 2018.